Media

Commercial Media

For Commercial Media enquiries:

5th April 2022

Groundbreaking LPLDL® cholesterol study nominated for NutraIngredients award

3rd March 2022

Latest LPLDL® human intervention study from ProBiotix Health highlights ‘promising findings’ on cholesterol reduction

9th February 2022

OptiBiotix targets sports nutrition market with launch of LeanBiome™

View All Commercial Media Posts

Scientific Media

For Scientific Media enquiries:

19th January 2022

LPLDL® from ProBiotix Health showcases statistically significant reductions in multiple coronary heart disease biomarkers in hypercholesterolemic adults

10th February 2021

OptiBiotix jointly funds new research project to understand how its microbiome modulation technologies could improve sleep, stress & anxiety

27th January 2021

New research indicates microbiome-modulator SlimBiome® may help to reduce weight, BMI and body fat

View All Scientific Media Posts

Investor Media

For Investor Relations Media

18th January 2022

Paul Cannings appointed Head of Operations & Quality at OptiBiotix

22nd October 2021

OptiBiotix leads sector with surging half year interim sales figures

12th April 2021

OptiBiotix Health announces René Kamminga as CEO of its subsidiary OptiBiotix Ltd

View All Investor Media Posts